What is CEOS stock price today?

CEOS (CeCors Inc) stock is trading at $0.01 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is CEOS stock going up or down today?

CEOS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CEOS stock now?

The decision to buy CEOS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CEOS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CEOS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CEOS stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CEOS is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CEOS's P/E ratio?

P/E ratio data for CEOS will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CEOS's market cap?

CEOS (CeCors Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is CEOS's price to book ratio?

Price-to-book ratio for CEOS is available on our dashboard along with other valuation metrics.

Does CEOS pay dividends?

CEOS does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CEOS's dividend yield?

CEOS does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CEOS stock a good long-term investment?

CEOS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CEOS's revenue growth rate?

Revenue growth data for CEOS is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CEOS are available on our dashboard with complete income statement analysis.

What are the risks of investing in CEOS?

Key risks for CEOS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CEOS compare to its competitors?

Compare CEOS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CEOS's performance and positioning.

What is CEOS's stock price target for 2026?

Our AI model provides price targets for CEOS based on fundamental analysis: Bull case $0.01 (+30%), Base case $0.01 (+15%), Bear case $0.01 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about CEOS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CEOS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CEOS's next earnings report?

CEOS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CEOS - CeCors Inc

NYSE * Healthcare * Medical Instruments & Supplies

$0.01

+$0.00 (+115.38%)

About CeCors Inc

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. The company was incorporated in 2002 and is based in Toronto, Canada.

CEOS Key Statistics

Market Cap

$0.87M

EPS

$-0.92

Employees

How CEOS Compares to Peers

CEOS is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CEOS(This stock)	$866.01K	N/A	0%	0.0%	-
UNHUnitedhealth Group	$285.06B	23.8	0%	0.0%	vs UNH
JNJJohnson &	$575.17B	21.8	0%	0.2%	vs JNJ
LLYEli Lilly	$809.09B	39.3	0%	0.3%	vs LLY
PFEPfizer Inc	$154.67B	20.0	-0%	0.1%	vs PFE
ABBVAbbvie Inc	$368.65B	87.6	0%	0.1%	vs ABBV

CeCors Inc Company Information

Headquarters: 17 Belfield Road, Toronto, ON, Canada, M9W1E8, undefined
Website: www.psykeyworld.com
Sector: Healthcare
Industry: Medical Instruments & Supplies

Data Updated: April 17, 2026 at 6:31 PM EDT

Ready to invest in CEOS?

Commission-free trading available. Affiliate links.

Upcoming Events for CEOS

Dashboard

Enter a ticker to analyze